{
  "main_header": {
    "sid": 1002820,
    "name": "ANG Lifesciences",
    "stock_name": "ANG Lifesciences",
    "full_name": "ANG Lifesciences India Ltd",
    "name_url": "stocks-analysis/ang-lifesciences",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "29.34",
    "chg": -0.15,
    "chgp": "-0.51%",
    "dir": -1,
    "prev_price": "29.49",
    "mcapval": "38.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540694,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE236W01016",
    "curr_date": "Apr 11, 12:46 PM",
    "curr_time": "01:09 AM",
    "bse_nse_vol": "2.11 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ang-lifesciences-1002820-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ANG Lifesciences India Ltd Sees Strong Buying Activity Amid Market Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-surges-4-99-today-gains-21-49-over-past-week-amid-market-decline-1693552",
        "imagepath": "",
        "date": "2025-04-03 09:35:47",
        "description": "ANG Lifesciences India Ltd is currently witnessing significant buying activity, with the stock showing a notable performance today. It has recorded a gain of 4.99%, outperforming the Sensex, which has declined by 0.58%. Over the past week, ANG Lifesciences has achieved consecutive gains, rising by 21.49%, while the Sensex has fallen by 1.85%. \n\nDespite a challenging year-to-date performance, where the stock is down 41.17% compared to the Sensex's decline of 2.52%, today's trading reflects a positive shift. The stock opened with a gap up at Rs 26.29 and reached an intraday high of the same price, indicating strong buyer interest at this level. \n\nThe Pharmaceuticals & Drugs sector has also shown resilience, gaining 4.06%, which may contribute to the buying pressure on ANG Lifesciences. The stock's current price is above its 5-day moving average but remains below its longer-term moving averages, suggesting a p..."
      },
      {
        "title": "ANG Lifesciences India Ltd Sees Strong Buying Activity Amid Positive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-surges-4-99-today-accumulates-15-71-gain-over-three-days-1671776",
        "imagepath": "",
        "date": "2025-04-02 09:35:42",
        "description": "ANG Lifesciences India Ltd is currently witnessing significant buying activity, with the stock gaining 4.99% today, outperforming the Sensex, which rose by only 0.54%. Over the past three days, ANG Lifesciences has shown a consecutive gain of 15.71%, indicating a positive momentum in the short term. The stock opened with a gap up at Rs 25.04 and reached an intraday high of the same price, reflecting strong buyer interest.\n\nIn terms of performance relative to the Sensex, ANG Lifesciences has had a mixed trajectory. While it has outperformed the index in the short term, its longer-term performance reveals a decline of 49.61% over the past year and 86.90% over the last three years. However, it has shown a notable increase of 123.57% over the past five years, although this is still below the Sensex's 170.41% gain in the same period.\n\nFactors contributing to the current buying pressure may include recent develop..."
      },
      {
        "title": "ANG Lifesciences India Ltd Sees Significant Buying Activity Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-surges-4-97-today-accumulates-10-21-gains-over-two-days-1661811",
        "imagepath": "",
        "date": "2025-04-01 12:15:13",
        "description": "ANG Lifesciences India Ltd is currently witnessing significant buying activity, with the stock rising by 4.97% today, contrasting sharply with the Sensex, which has declined by 1.59%. This marks the second consecutive day of gains for ANG Lifesciences, accumulating a total return of 10.21% over this period. The stock opened with a notable gap up of 4.89% and reached an intraday high of Rs 23.85.\n\nDespite today's positive performance, ANG Lifesciences has faced challenges over the longer term, with a 1-month decline of 29.83% and a staggering 87.52% drop over the past three years. In comparison, the Sensex has shown resilience, gaining 2.93% over the past year and 28.53% over three years.\n\nThe current buying pressure may be attributed to various factors, including potential market corrections, sector-specific developments, or investor sentiment shifting towards microcap stocks. However, ANG Lifesciences cont..."
      },
      {
        "title": "ANG Lifesciences India Ltd Sees 4.99% Surge Amidst Market Decline and New Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-ltd-surges-4-99-today-after-seven-days-of-decline-hits-all-time-low-1642705",
        "imagepath": "",
        "date": "2025-03-28 12:30:13",
        "description": "ANG Lifesciences India Ltd is witnessing significant buying activity today, with the stock rising by 4.99%. This performance stands in stark contrast to the Sensex, which has declined by 0.30%. Notably, this uptick comes after a streak of seven consecutive days of declines, indicating a potential trend reversal.\n\nDespite today's gains, ANG Lifesciences has faced considerable challenges over the past week, month, and year, with declines of 10.94%, 33.16%, and 49.60%, respectively. Over the last three years, the stock has dropped by 88.47%, while the Sensex has appreciated by 34.35% during the same period. However, the stock has shown resilience over the past five years, with an increase of 88.08%, although this is significantly lower than the Sensex's 159.52% rise.\n\nToday's trading session opened with a gap up, and the stock reached a new 52-week low of Rs. 21.03. ANG Lifesciences is currently trading below ..."
      },
      {
        "title": "ANG Lifesciences Faces Challenges Amid Significant Stock Volatility and Declining Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-52-week-low-amid-ongoing-financial-struggles-7-1654936",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ANGLifesciences_priceRelatedfactors_833421.png",
        "date": "2025-03-28 09:59:06",
        "description": "ANG Lifesciences India has reached a new 52-week low, reflecting significant challenges in the Pharmaceuticals & Drugs sector. The company has experienced a substantial decline in net sales and operating profit over the past five years, alongside a high debt-to-EBITDA ratio and a notable percentage of pledged promoter shares."
      },
      {
        "title": "ANG Lifesciences Faces Financial Struggles Amid Significant Stock Decline and High Debt Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-52-week-low-amid-ongoing-financial-struggles-8-1654937",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ANGLifesciences_priceRelatedfactors_833420.png",
        "date": "2025-03-28 09:59:01",
        "description": "ANG Lifesciences India has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company has reported ongoing operating losses for 11 consecutive quarters, with troubling declines in net sales and operating profit, alongside a high debt-to-EBITDA ratio and pledged promoter shares."
      },
      {
        "title": "ANG Lifesciences Faces Ongoing Challenges Amid Significant Stock Volatility and Declining Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-52-week-low-amid-ongoing-financial-struggles-6-1639759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ANGLifesciences_priceRelatedfactors_833422.png",
        "date": "2025-03-28 09:58:56",
        "description": "ANG Lifesciences India has hit a 52-week low, reflecting a significant decline over the past year, contrasting with the Sensex's positive performance. The company has reported negative results for 11 consecutive quarters, with declining net sales and high debt levels, raising concerns about its financial stability."
      },
      {
        "title": "ANG Lifesciences Faces Ongoing Challenges Amidst Stock Volatility and High Debt Levels",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-52-week-low-amid-significant-stock-decline-and-financial-losses-1639761",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ANGLifesciences_priceRelatedfactors_833419.png",
        "date": "2025-03-28 09:58:53",
        "description": "ANG Lifesciences India has reached a new 52-week low, reflecting a challenging year with a significant stock decline. The company has reported negative results for 11 consecutive quarters, with substantial decreases in net sales and operating profits. High debt levels and pledged promoter shares contribute to ongoing bearish trends."
      },
      {
        "title": "ANG Lifesciences India Faces Ongoing Challenges Amid Significant Stock Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-52-week-low-amid-ongoing-financial-struggles-9-1654938",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ANGLifesciences_priceRelatedfactors_833415.png",
        "date": "2025-03-28 09:58:47",
        "description": "ANG Lifesciences India has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company has reported negative results for 11 consecutive quarters, with substantial decreases in net sales and operating profits. High debt levels and pledged promoter shares add to the pressure."
      }
    ],
    "total": 50,
    "sid": "1002820",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/ang-lifesciences-india-1002820"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "01-Apr-2025",
      "details": "Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time read with Companys Code of Conduct to regulate monitor and report the trading of equity shares. The trading window for dealing in the securities of company shall remain closed from 1st April 2025 for the insider designated persons and their immediate relatives till the end of 48 hours after declaration of Results for the quarter ending 31st March 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "20-Mar-2025",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that Mr. Karun Singh Group Opertaions Head of the Company had a Zoom meet with Mr. Milin Ramani on 20-MArch-2025.",
      "source": "BSE"
    },
    {
      "caption": "Appointment of Company Secretary and Compliance Officer",
      "datetime": "12-Mar-2025",
      "details": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 the Board of Directors at the meeting held on today March 12 2025 have considered and appointed Ms. Harshita Aggarwal as the Company Secretary and Compliance Officer of the company w.e.f March 12 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has declared <strong>10%</strong> dividend, ex-date: 02 Nov 21",
          "dt": "2021-11-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has announced <strong>1:4</strong> bonus issue, ex-date: 13 Jul 22",
          "dt": "2022-07-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

ANG Lifesciences India Ltd Sees Strong Buying Activity Amid Market Shift

2025-04-03 09:35:47

ANG Lifesciences India Ltd is currently witnessing significant buying activity, with the stock showing a notable performance today. It has recorded a gain of 4.99%, outperforming the Sensex, which has declined by 0.58%. Over the past week, ANG Lifesciences has achieved consecutive gains, rising by 21.49%, while the Sensex has fallen by 1.85%. Despite a challenging year-to-date performance, where the stock is down 41.17% compared to the Sensex's decline of 2.52%, today's trading reflects a positive shift. The stock opened with a gap up at Rs 26.29 and reached an intraday high of the same price, indicating strong buyer interest at this level. The Pharmaceuticals & Drugs sector has also shown resilience, gaining 4.06%, which may contribute to the buying pressure on ANG Lifesciences. The stock's current price is above its 5-day moving average but remains below its longer-term moving averages, suggesting a p...

Read More

ANG Lifesciences India Ltd Sees Strong Buying Activity Amid Positive Momentum

2025-04-02 09:35:42

ANG Lifesciences India Ltd is currently witnessing significant buying activity, with the stock gaining 4.99% today, outperforming the Sensex, which rose by only 0.54%. Over the past three days, ANG Lifesciences has shown a consecutive gain of 15.71%, indicating a positive momentum in the short term. The stock opened with a gap up at Rs 25.04 and reached an intraday high of the same price, reflecting strong buyer interest. In terms of performance relative to the Sensex, ANG Lifesciences has had a mixed trajectory. While it has outperformed the index in the short term, its longer-term performance reveals a decline of 49.61% over the past year and 86.90% over the last three years. However, it has shown a notable increase of 123.57% over the past five years, although this is still below the Sensex's 170.41% gain in the same period. Factors contributing to the current buying pressure may include recent develop...

Read More

ANG Lifesciences India Ltd Sees Significant Buying Activity Amid Broader Market Decline

2025-04-01 12:15:13

ANG Lifesciences India Ltd is currently witnessing significant buying activity, with the stock rising by 4.97% today, contrasting sharply with the Sensex, which has declined by 1.59%. This marks the second consecutive day of gains for ANG Lifesciences, accumulating a total return of 10.21% over this period. The stock opened with a notable gap up of 4.89% and reached an intraday high of Rs 23.85. Despite today's positive performance, ANG Lifesciences has faced challenges over the longer term, with a 1-month decline of 29.83% and a staggering 87.52% drop over the past three years. In comparison, the Sensex has shown resilience, gaining 2.93% over the past year and 28.53% over three years. The current buying pressure may be attributed to various factors, including potential market corrections, sector-specific developments, or investor sentiment shifting towards microcap stocks. However, ANG Lifesciences cont...

Read More

ANG Lifesciences India Ltd Sees 4.99% Surge Amidst Market Decline and New Low

2025-03-28 12:30:13

ANG Lifesciences India Ltd is witnessing significant buying activity today, with the stock rising by 4.99%. This performance stands in stark contrast to the Sensex, which has declined by 0.30%. Notably, this uptick comes after a streak of seven consecutive days of declines, indicating a potential trend reversal. Despite today's gains, ANG Lifesciences has faced considerable challenges over the past week, month, and year, with declines of 10.94%, 33.16%, and 49.60%, respectively. Over the last three years, the stock has dropped by 88.47%, while the Sensex has appreciated by 34.35% during the same period. However, the stock has shown resilience over the past five years, with an increase of 88.08%, although this is significantly lower than the Sensex's 159.52% rise. Today's trading session opened with a gap up, and the stock reached a new 52-week low of Rs. 21.03. ANG Lifesciences is currently trading below ...

Read More

ANG Lifesciences Faces Challenges Amid Significant Stock Volatility and Declining Performance Metrics

2025-03-28 09:59:06

ANG Lifesciences India has reached a new 52-week low, reflecting significant challenges in the Pharmaceuticals & Drugs sector. The company has experienced a substantial decline in net sales and operating profit over the past five years, alongside a high debt-to-EBITDA ratio and a notable percentage of pledged promoter shares.

Read More

ANG Lifesciences Faces Financial Struggles Amid Significant Stock Decline and High Debt Concerns

2025-03-28 09:59:01

ANG Lifesciences India has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company has reported ongoing operating losses for 11 consecutive quarters, with troubling declines in net sales and operating profit, alongside a high debt-to-EBITDA ratio and pledged promoter shares.

Read More

ANG Lifesciences Faces Ongoing Challenges Amid Significant Stock Volatility and Declining Metrics

2025-03-28 09:58:56

ANG Lifesciences India has hit a 52-week low, reflecting a significant decline over the past year, contrasting with the Sensex's positive performance. The company has reported negative results for 11 consecutive quarters, with declining net sales and high debt levels, raising concerns about its financial stability.

Read More

ANG Lifesciences Faces Ongoing Challenges Amidst Stock Volatility and High Debt Levels

2025-03-28 09:58:53

ANG Lifesciences India has reached a new 52-week low, reflecting a challenging year with a significant stock decline. The company has reported negative results for 11 consecutive quarters, with substantial decreases in net sales and operating profits. High debt levels and pledged promoter shares contribute to ongoing bearish trends.

Read More

ANG Lifesciences India Faces Ongoing Challenges Amid Significant Stock Volatility

2025-03-28 09:58:47

ANG Lifesciences India has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company has reported negative results for 11 consecutive quarters, with substantial decreases in net sales and operating profits. High debt levels and pledged promoter shares add to the pressure.

Read More

View All News